First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q2 2026 (June 30)30holders −2
1new positions
3sold out
1famous investor
$38.19avg. 13F price*
At the end of Q2 2026, 30 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were LPL Financial LLC ($5.8M), Oppenheimer & Co. Inc. ($4.4M) and Raymond James Financial Inc. ($2.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $168K |
| Exits | 3 | $498K |
All 13F filers, Q1 2026 → Q2 2026: 156,543 shares bought and 76,951 shares sold, net +79,592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| LPL Financial LLC | 0.00% | Reduce -14.7% | 151,471 | $5.8M |
| Oppenheimer & Co. Inc. | 0.05% | Add +181.6% | 114,183 | $4.4M |
| Raymond James Financial Inc. | 0.00% | Add +369.1% | 54,968 | $2.1M |
| Truist Financial Corp. | 0.00% | Reduce -8.7% | 52,126 | $2.0M |
| Marshall Investment Management, LLC | 0.60% | Reduce -15.8% | 38,080 | $1.5M |
| Ameritas Investment Partners, Inc. | 0.03% | Add +13.1% | 33,987 | $1.3M |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +56.2% | 30,525 | $1.2M |
| Nilsine Partners, LLC | 0.07% | Add +3.5% | 28,057 | $1.1M |
| Royal Bank of Canada | 0.00% | Add +28544.0% | 14,322 | $547K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -29.1% | 13,730 | $524K |
| Commonwealth Equity Services, LLC | 0.00% | Add +49.3% | 10,734 | $410K |
| OneDigital Investment Advisors LLC | 0.00% | No change | 9,325 | $356K |
| Sound Income Strategies, LLC | 0.01% | No change | 8,627 | $329K |
| Envestnet Asset Management Inc. | 0.00% | Reduce -52.6% | 8,340 | $319K |
| Stratos Wealth Partners, LTD. | 0.00% | Add +9.3% | 8,180 | $312K |
| Citadel Advisors | 0.00% | Reduce -33.5% | 6,822 | $261K |
| Beto Financial Group, LLC | 0.14% | No change | 6,833 | $260K |
| Morgan Stanley | 0.00% | Add +0.0% | 5,917 | $226K |
| Flagship Harbor Advisors, LLC | 0.01% | Reduce -12.3% | 5,632 | $215K |
| International Assets Investment Management, LLC | 0.01% | New | 4,421 | $168K |
| Bank of Montreal | 0.00% | Reduce -53.0% | 4,326 | $165K |
| Osaic Holdings, Inc. | 0.00% | Add +45.1% | 2,556 | $98K |
| Lanark Financial, Inc. | 0.00% | Reduce -12.1% | 1,162 | $44K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,046 | $40K |
| Harbour Investments, Inc. | 0.00% | Add +11.1% | 929 | $35K |
| Compass Financial Management LLC | 0.00% | — | 756 | $29K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $23K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $17K |
| Princeton Global Asset Management LLC | 0.00% | No change | 150 | $6K |
| Wells Fargo & Company | 0.00% | Reduce -50.0% | 1 | $52 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.